The Effect of Obesity on Contralateral Suppression in Patients With Mu
Otoacoustics Emissions Contralateral Supression Test
We could not find results for this trial
What it found
We found no results in the registry or in papers.
This trial finished 2 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- DPOAE with Contralateral Suppression
What it measured
Main measures
Contralateral supression
Within 12 months of MS diagnosis
Other measures (1)
DPOAE Amplitude Levels
Within 12 months of MS diagnosis
Who could take part
MS (type not specified) · 18 to 50
Show the full criteria
Inclusion criteria
Eligibility Criteria Minimum Age: 18 Years Maximum Age: 50 Years Sex: All Gender Based: No Accepts Healthy Volunteers: No Inclusion Criteria: Ability to cooperate with the applied scales and auditory tests Normal findings in otoscopic examination (ear, nose, and throat evaluation) Absence of any neurological, psychiatric, or metabolic disease other than Multiple Sclerosis (MS) No history of significant noise exposure For female participants: not pregnant and not in the menstrual period
Exclusion criteria
Presence of active middle ear pathology (e.g., otitis media, tympanic membrane perforation) Abnormal tympanometric findings Hearing loss exceeding 20 dB HL at any frequency between 500-4000 Hz Neurological or psychiatric disorders other than MS History of ear surgery or otologic trauma Use of medications known to affect auditory function (e.g., ototoxic drugs) Inability to cooperate with audiological testing Pregnancy Diagnosis of metabolic or endocrine disorders (e.g., uncontrolled diabetes, thyroid dysfunction) Body Mass Index (BMI) below 18.5 (underweight) or above 40 (morbid obesity)
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
This study investigates how obesity may affect the auditory system in individuals with Multiple Sclerosis (MS). Specifically, it examines the brain's ability to process and suppress sounds (contralateral suppression). The test is painless and brief. It provides information about the condition of the auditory nerve pathways. The goal is to better understand how obesity may influence this system and to improve follow-up and support for individuals with MS.
Papers
Loading reviews and guidelines…
History
Started
Jun 2022
Main results due
Jun 2024
Finished
Jun 2025